Shockwave Medical, Inc. v. Cardiovascular Systems, Inc., No. 20-2314 (Fed. Cir. Jan. 18, 2022)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

SHOCKWAVE MEDICAL, INC.,

Appellant

v.

CARDIOVASCULAR SYSTEMS, INC.,

Appellee

ANDREW HIRSHFELD, PERFORMING THE

FUNCTIONS AND DUTIES OF THE UNDER

SECRETARY OF COMMERCE FOR

INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK

OFFICE,

Intervenor

2020-2314

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019-00408.

JUDGMENT

DAVID C. MCPHIE, Irell & Manella LLP, Newport Beach, CA, argued for appellant. Also represented by

2STEPHEN PAYNE; MICHAEL RICHARD FLEMING, Los Angeles, CA, WILLIAM ALCIATI, GREG GARDELLA, Gardella Grace PA, Washington, DC. MARK CHRISTOPHER NELSON, Barnes & Thornburg LLP, Dallas, TX, argued for appellee. Also represented by JUANITA DELOACH; JEFFREY STONE, Minneapolis, MN. BENJAMIN T. HICKMAN, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for intervenor. Also represented by MARY L. KELLY, THOMAS W. KRAUSE, FARHEENA YASMEEN RASHEED.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: